Nobel prize in medicine awarded to scientists for work on microRNA

Original article by Nicola Davis
The Guardian – Page: Online : 8-Oct-24

The Nobel assembly has announced that the 2024 Nobel prize in medicine has been awarded to Victor Ambros of the University of Massachusetts medical school, and Gary Ruvkun of the Harvard medical school and Massachusetts general hospital. Ambros and Ruvkun won the award for the discovery of microRNA and its role in post-transcriptional gene regulation, with Olle Kampe, vice-chair of the Nobel committee for physiology or medicine, commenting that "microRNAs are important for our understanding of embryological development, normal cell physiology, and diseases such as cancer".

CORPORATES
NOBEL FOUNDATION, UNIVERSITY OF MASSACHUSETTS, HARVARD MEDICAL SCHOOL, MASSACHUSETTS GENERAL HOSPITAL

Research on how cells adapt to oxygen earns trio Nobel Prize for medicine

Original article by
The New Daily – Page: Online : 8-Oct-19

Scientists William Kaelin, Gregg Semenza and Peter Ratcliffe have been awarded the 2019 Nobel Prize for Medicine for their work in determining how cells adapt to oxygen levels. In awarding the prize to Kaelin, Semenza and Ratcliffe, the Nobel Assembly at Sweden’s Karolinska Institute noted that oxygen sensing is central to a large number of diseases. Their work is tipped to help find new methods for combating diseases such as cancer and anaemia.

CORPORATES
KAROLINSKA INSTITUTE

Antidepressants may harm a healthy brain

Original article by Jill Margo
The Australian Financial Review – Page: 42 : 9-Sep-15

A survey by the OECD in 2013 found that Australia boasts the second-highest use of antidepressant drugs per capital among 33 nations. New medical research suggests that antidepressant drugs might significant affect the areas of the human brain that regulate a person’s mood and memory. Previous research has found that people who suffer from depression generally have smaller volumes of these areas of the brain, but the new research may have implications for the use of antidepressants to treat other conditions such as anxiety and post-traumatic stress disorder.

CORPORATES
ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT, UNIVERSITY OF NEW SOUTH WALES, BLACK DOG INSTITUTE

Theatre of dreams nightmare

Original article by Jill Margo
The Australian Financial Review – Page: 46 : 17-Sep-14

A study of accidental awareness during general anaesthesia has been published. The experiences of 400 patients were analysed. The experience was neutral for about half the patients, but terrifying for some. The study found that accidental awareness occurs for one in every 19,000 patients, rather than one in 6,000 as previously estimated. Most episodes were short and before or after surgery

CORPORATES
ROYAL COLLEGE OF ANAESTHETISTS, ASSOCIATION OF ANAESTHETISTS OF GREAT BRITAIN

New drug regimen gives hope to millions

Original article by Julia Medew
The Sydney Morning Herald – Page: 7 : 22-Jul-14

A new treatment called PaMZ has been shown to fight tuberculosis (TB) while still allowing anti-retroviral drugs to be used that target the human immunodeficiency virus (HIV). The 20th international congress on the Acquired Immunodeficiency Syndrome (AIDS) in Melbourne on 21 July 2014 heard from Global TB Alliance senior medical officer Daniel Everitt on the promising clinical trials. TB accounts for about 20% of all deaths among those suffering from HIV or AIDS. PaMZ may be widely available from 2018

CORPORATES
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT